TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Viiv Healthcare UK (NO.5)
US Patent
Viiv Healthcare UK (NO.5)
US Patent
Affinity DataEC50: 8nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair